Skip to content
Screener

Cencora COR Q2 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$78.4BMiss by $2.7B
EPS$4.75Miss by $0.07
Revenue estimate$81.1B
EPS estimate$4.82

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$88.0B
EPS estimate$4.57

Financials

Q2 2026

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
CapEx$165.6M+28.3%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$61.11B+13.4%
Enterprise value$71.12B+20.6%
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp

Returns & leverage

See full
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Segments

By product

See full
Alliance Healthcare$6.5B+12.9%
Animal Health$1.4B+5.3%
Other Healthcare Solutions$1.0B+13.5%
Other non-strategic businesses$619.8M+4.5%

By segment

See full
U.S. Healthcare Solutions$68.8B+2.9%
International Healthcare Solutions$7.6B+13.0%

FAQ

When did Cencora report Q2 2026 earnings?
Cencora (COR) reported Q2 2026 earnings on May 6, 2026 before market open.
What were Cencora's Q2 2026 revenue and EPS?
Cencora reported revenue of $78.4B and eps of $4.75 for Q2 2026.
Did Cencora beat estimates in Q2 2026?
Revenue missed the consensus estimate of $81.1B by $2.7B. EPS missed the consensus estimate of $4.82 by $0.07.
How did Cencora's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.8% from $75.5B a year earlier and eps grew 7.5% from $4.42.
Where can I find Cencora's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001140859-26-000018) and the 10-Q periodic report (0001140859-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.